Clinical outcomes of dialysis patients after implantation of DES: Meta analysis and systematic review of literature

Minerva Cardioangiologica

Volumn 57, Issue 3, 2009, Pages 291-297

  Athappan, G ^a   Ponniah, T ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MADURAI MEDICAL COLLEGE   (India)

Author keywords

Dialysis; Drug eluting stents; Kidney failure, chronic

Indexed keywords

ANGIOCARDIOGRAPHY; BARE METAL STENT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; KIDNEY FAILURE; META ANALYSIS; MORTALITY; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; RENAL DIALYSIS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 69549127714     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Bocksch W, Fateh-Moghadam S, Mueller E, Huehns S, Waigand J, Dietz R.Percutaneous Coronary Intervention in Patients with End-Stage Renal Disease. Kidney Blood Press Res 2005;28:275-279
2. Herzog CA, Ma JZ, Collins AJ. Long term outcome of renal transplant recipients in the United States after coronary angioplasty, coronary stenting and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207-2211
3. Mintz GS, Weissman NJ. Intravascular ultrasound in the drug eluting stent era . J Am Coll Cardiol 2006;48:421-429
4. Boston Scientific. Homepage. [Internet]. Available from http://www.bostonscientific-international.com/AboutUs/ClinicalTrials.bsci/,/ method/CLINICAL-TRIALS-DETAIL/navRelId/1004.1013/id/10080562/seo.serve [cited 2009, May 13].
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323
6. Cochrane IMS [Internet]. Available from http://www.cc-ims.net/RevMan/ RevMan5 [cited 2009, May 13].
7. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T et al. One year clinical outcomes of dialysis patients after implantation with Sirolimus eluting coronary stents. Circ J 2008;72:1430-1435
8. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R et al. Sirolimus eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on Hemodialysis. Circ J 2008;72:56-60.
9. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T et al. Impact of drug eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007;71:1525-1529
10. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug eluting stents vs bare metal stents in dialysis patients. J Invasive Cardiol 2006;18:577-583
11. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD et al. Impact of drug eluting stents on outcomes of patients with end stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006;18:405-408
12. United States Renal Disease System. USRDS 1997 Annual Data Report 1997; Bethesda, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases pp 91-101.
13. Luke RG. Chronic renal failure; a vasculopathic state. N Engl J Med 1998;339:841-843
14. Amann K, Ritz E. Cardiac disease in chronic uremia: pathophysiology. Adv Ren Replace Ther 1997;4:212-224
15. Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436
16. Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ Jr, Baim DS et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000;86:485-489
17. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002;55:66-72.
18. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 1986;43:139-143
19. Sabo RS, Bartoli F, Apitz-Castro R. In vivo platelet hyperactivity, another risk factor for patients under continuous ambulatory peritoneal dialysis. Nephron 1988;49:228-230
20. Notohamiprodjo M, Andrassy K, Bommer J, Kirschfink M, Rother U, Ritz E. Dialysis membranes and the coagulation system. Blood Purif 1986;4:130-141
21. Schoebel FC, Gradaus F, Ivens K, Heering P, Jax TW, Grabensee B et al. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: A case-control study using quantitative coronary angiography. Heart 1997;78:337-342